Bloomsbury Genetic Therapies launches with Seed financing of £5 million to develop potentially curative gene therapy treatments for rare neurological and metabolic diseasesLondon, UK, 7 October 2022 – Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a biotechnology company developin.
DUBAI, 11th February, 2022 (WAM) As part of the UK Pavilion at Expo 2020 Dubai’s How will we Thrive? week program, Prof Claire Booth, Mahboubian Professor in Gene Therapy at UCL Great Ormond Institute of Child Health (UCL GOS ICH) and Consultant in Paediatric Immunology, Great Ormond Street Hospital (GOSH), was invited to give a virtual seminar to discuss her world-leading research in gene therapy.
GOSH has been at the cutting edge of the gene therapy field for more than 20 years, and much.